Surprisingly, administration of IL-22BP-Fc, an Fc fusion protein containing the antagonizing IL-22 binding protein (IL-22BP), ameliorated the colitis symptoms in MSC-/- mice (52). This evidence concerns the gene IL22RA2 and colitis.